Xeris Biopharma Holdings, Inc.
SEC CIK 1867096 · XERS · last insider filing 2026-06-05
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Persky Marla | Director | filed 2021 - 2026 |
| Johnson John H | Director | filed 2021 - 2026 |
| Kong Garheng | Director | filed 2021 - 2026 |
| Bormann-Kennedy Barbara-Jean Anne | Director | filed 2021 - 2026 |
| Halkuff Dawn | Director | filed 2021 - 2026 |
| Brady James Aloysius | Director | filed 2025 - 2026 |
| Shannon John Patrick Jr | Director · See Remarks | filed 2021 - 2026 |
| Sherman Jeffrey W | Director | filed 2021 - 2025 |
| Schmid John P. | Director | filed 2021 - 2024 |
| Fairley Ricki Louise | Director | filed 2023 - 2024 |
| Edick Paul R | Director · See Remarks | filed 2021 - 2024 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Hecht Beth | See Remarks | filed 2021 - 2026 |
| Mcculloch Kevin | See Remarks | filed 2024 - 2026 |
| Pieper Steven | See Remarks | filed 2021 - 2026 |
| Nguyen Anh Tu | See Remarks | filed 2025 - 2026 |
| Johnson Kenneth Erland | See Remarks | filed 2021 - 2025 |
| Prestrelski Steven | Chief Scientific Officer | filed 2021 - 2023 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.